Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

High Mobility Group Box-1 and Blood–Brain Barrier Disruption
Masahiro Nishibori, Dengli Wang, Daiki Ousaka, et al.
Cells (2020) Vol. 9, Iss. 12, pp. 2650-2650
Open Access | Times Cited: 90

Showing 1-25 of 90 citing articles:

Factors influencing the blood-brain barrier permeability
Yibin Zhao, Lin Gan, Li Ren, et al.
Brain Research (2022) Vol. 1788, pp. 147937-147937
Open Access | Times Cited: 130
HMGB1: A New Target for Ischemic Stroke and Hemorrhagic Transformation
Jiamin Li, Zixin Wang, Jiameng Li, et al.
Translational Stroke Research (2024)
Open Access | Times Cited: 18
Extracellular cold-inducible RNA-binding protein in CNS injury: molecular insights and therapeutic approaches
Dmitriy Lapin, Archna Sharma, Ping Wang
Journal of Neuroinflammation (2025) Vol. 22, Iss. 1
Open Access | Times Cited: 2
The role of damage associated molecular pattern molecules (DAMPs) and permeability of the blood-brain barrier in depression and neuroinflammation
María Fernanda Serna-Rodríguez, Sofía Bernal‐Vega, José Alfonso Ontiveros-Sánchez de la Barquera, et al.
Journal of Neuroimmunology (2022) Vol. 371, pp. 577951-577951
Closed Access | Times Cited: 65
The role of high mobility group box 1 in neuroinflammatory related diseases
Jialu Mo, Jiao Hu, Xianglin Cheng
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114541-114541
Open Access | Times Cited: 23
Blood-brain barrier disruption: a culprit of cognitive decline?
Ji Che, Yinying Sun, Yixu Deng, et al.
Fluids and Barriers of the CNS (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 14
High Mobility Group Box 1: Biological Functions and Relevance in Oxidative Stress Related Chronic Diseases
Simona Taverna, Alessandro Tonacci, Maria Ferraro, et al.
Cells (2022) Vol. 11, Iss. 5, pp. 849-849
Open Access | Times Cited: 36
The role of triggering receptor expressed on myeloid cells-1 (TREM-1) in central nervous system diseases
Chunyan Zhang, Xugang Kan, Baole Zhang, et al.
Molecular Brain (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 30
HMGB1 in nervous system diseases: A common biomarker and potential therapeutic target
Di Mao, Zheng Yuan, Fenfen Xu, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 29
Engeletin alleviates cerebral ischemia reperfusion‐induced neuroinflammation via the HMGB1/TLR4/NF‐κB network
Yangyang Xu, Jie Zhang, Fei Gao, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 12, pp. 1653-1663
Open Access | Times Cited: 20
High Mobility Group Box Protein (HMGB1): A Potential Therapeutic Target for Diabetic Encephalopathy
Udit Kumar Dash, Debashree Mazumdar, Santosh Singh
Molecular Neurobiology (2024) Vol. 61, Iss. 10, pp. 8188-8205
Closed Access | Times Cited: 7
HMGB1 signaling pathway in diabetes-related dementia: Blood-brain barrier breakdown, brain insulin resistance, and Aβ accumulation
Jae‐Ho Jeong, Dong Hoon Lee, Juhyun Song
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 112933-112933
Open Access | Times Cited: 27
The Neuroinflammatory Role of Pericytes in Epilepsy
Gaku Yamanaka, Fuyuko Takata, Yasufumi Kataoka, et al.
Biomedicines (2021) Vol. 9, Iss. 7, pp. 759-759
Open Access | Times Cited: 32
The Cellular Senescence Factor Extracellular HMGB1 Directly Inhibits Oligodendrocyte Progenitor Cell Differentiation and Impairs CNS Remyelination
Megan E. Rouillard, Jingwen Hu, Pearl A. Sutter, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 20
HMGB1 Inhibition to Ameliorate Organ Failure and Increase Survival in Trauma
Zhangsheng Yang, Milomir O. Simovic, Peter R. Edsall, et al.
Biomolecules (2022) Vol. 12, Iss. 1, pp. 101-101
Open Access | Times Cited: 20
Pathophysiological Role of Microglial Activation Induced by Blood-Borne Proteins in Alzheimer’s Disease
Sehwan Kim, Chanchal Sharma, Un Ju Jung, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1383-1383
Open Access | Times Cited: 13
Underlying Mechanisms of Brain Aging and Neurodegenerative Diseases as Potential Targets for Preventive or Therapeutic Strategies Using Phytochemicals
Hamid M. Abdolmaleky, Jin‐Rong Zhou
Nutrients (2023) Vol. 15, Iss. 15, pp. 3456-3456
Open Access | Times Cited: 13
Complexity in Genetic Epilepsies: A Comprehensive Review
Cassandra Rastin, Laila C. Schenkel, Bekim Sadiković
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14606-14606
Open Access | Times Cited: 13
Glycyrrhizin alleviates brain injury in necrotizing enterocolitis model mice by suppressing HMGB1/TLR4 pathway
Qian Sun, Ling Li, Jing Li, et al.
International Immunopharmacology (2025) Vol. 150, pp. 114294-114294
Closed Access
Neurons Are a Primary Driver of Inflammation via Release of HMGB1
Huan Yang, Jan Andersson, Michael Brines
Cells (2021) Vol. 10, Iss. 10, pp. 2791-2791
Open Access | Times Cited: 27
Modulation of α7nAchR by Melatonin Alleviates Ischemia and Reperfusion-Compromised Integrity of Blood–Brain Barrier Through Inhibiting HMGB1-Mediated Microglia Activation and CRTC1-Mediated Neuronal Loss
Shuang Chen, Yanyun Sun, Fei Li, et al.
Cellular and Molecular Neurobiology (2021) Vol. 42, Iss. 7, pp. 2407-2422
Open Access | Times Cited: 25
Transporter Regulation in Critical Protective Barriers: Focus on Brain and Placenta
Valerio Taggi, Mario Riera Romo, Micheline Piquette‐Miller, et al.
Pharmaceutics (2022) Vol. 14, Iss. 7, pp. 1376-1376
Open Access | Times Cited: 18
HMGB1 in the mPFC governs comorbid anxiety in neuropathic pain
Yu Du, Cenglin Xu, Jie Yu, et al.
The Journal of Headache and Pain (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 17
YY1 (Yin‐Yang 1), a transcription factor regulating systemic inflammation, is involved in cognitive impairment of depression
Jing Lü, Kangyu Jin, Jianping Jiao, et al.
Psychiatry and Clinical Neurosciences (2022) Vol. 77, Iss. 3, pp. 149-159
Closed Access | Times Cited: 17
Annao Pingchong decoction alleviate the neurological impairment by attenuating neuroinflammation and apoptosis in intracerebral hemorrhage rats
Guo Chun, Xuqing Zhou, Xu Wang, et al.
Journal of Ethnopharmacology (2023) Vol. 310, pp. 116298-116298
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top